Research News

Liraglutide improves weight loss in people who are overweight or obese, study shows

BMJ 2015; 351 doi: http://dx.doi.org/10.1136/bmj.h3545 (Published 02 July 2015) Cite this as: BMJ 2015;351:h3545
  1. Susan Mayor
  1. 1London

Liraglutide significantly reduces body weight and improves metabolic control in people who are obese or overweight and have dyslipidaemia or hypertension, a randomised trial reported in the New England Journal of Medicine has shown.1

The study randomised 3731 people who were obese, had a body mass index (BMI) of at least 30, or were overweight (BMI>27), and who had treated or untreated dyslipidaemia or hypertension, to treatment with once daily injections of liraglutide (3.0 mg) or placebo in addition to counselling on lifestyle changes.

Liraglutide …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe